AKER

Akers Biosciences Inc.

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

AKER price

Akers Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AKER

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals AKER

Valuation

P/E

0.00

Sector -4.26

Industry -4.26

P/BV

0.00

Sector 2.11

Industry 2.11

P/Revenue (PSR)

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

Sector 1.25

Industry 1.25

P/Net Current Assets

Sector -5.47

Industry -5.47

P/Working Capital

Sector -1.10

Industry -1.10

EPS

-2.11

Sector -1.94

Industry -1.94

BVPS

4.01

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

-52.10%

Sector 38.90%

Industry 38.90%

EBITDA Margin

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

-100.00%

Sector -36.74%

Industry -36.74%

Net Profit Margins

-100.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-52.60%

Sector -61.50%

Industry -61.50%

ROA

-49.11%

Sector -63.85%

Industry -63.85%

ROIC

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

Sector -0.60

Industry -0.60

Gross Debt / Equity

Sector -0.83

Industry -0.83

Equity/Assets

0.93

Sector 0.43

Industry 0.43

Liabilities/Assets

0.07

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

39.85%

Sector -

Industry -

Fundamentals AKER

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AKER Akers Biosciences Inc.	$0.00	-	0.00%	0.00	0.00	-52.60%	-100.00%
JNJ Johnson & Johnson	$265.78	55.14%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$28.16	23.05%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$258.54	28.04%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.26	-13.44%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$149.54	82.80%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$164.84	5.63%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.95	48.54%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$75.02	-50.44%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$807.71	40.12%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$436.99	56.32%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$106.92	46.57%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$890.51	31.53%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$547.55	41.42%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.13	61.46%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.87	7.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$221.50	62.01%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AKER Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Akers Biosciences

Akers Biosciences Inc.

Average Investor10 user rating

4.0 (1 people)

United States

37 years

Founded: 1989

2014

Time since IPO - 12 years

4

Employees

Akers Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $33.42 million.

The company employs approximately 4 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Akers Biosciences Inc. reported $361.63 Thousand in revenue, generating net income of $-17.58 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AKER.

Market cap

Net worth

$33.42 million

$33,423,792.00

Assets

$35.80 million

$35,797,851.00

Total Shares Outstanding

8.33 million

8,326,000

Average Daily Trading Volume

$1.18 million

$1,178,457.24

Sector

Health Care

Industry

Biotechnology

AKER

AKER revenue and profits

Financial Results AKER

DRAG THE FRAME TO SEE MORE DATA

AKER cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$890.51 31,43% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.13 59,28% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$265.78 56,06% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$258.54 28,31% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$149.54 86,71% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$164.84 5,67% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$28.16 24,65% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$890.51 31,43% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.13 59,28% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$265.78 56,06% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$258.54 28,31% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$149.54 86,71% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$164.84 5,67% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$28.16 24,65% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Akers Biosciences (AKER) today?

A cotação de Akers Biosciences (AKER) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Akers Biosciences (AKER) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Akers Biosciences (AKER) e dados de ações do Ibovespa e mercados internacionais.

Quando Akers Biosciences (AKER) paga dividendos?

Akers Biosciences (AKER) não distribuiu dividendos no último ano.

Is Akers Biosciences (AKER) a good investment?

Atualmente, Akers Biosciences (AKER) está cotada a US$ 0.00, com um P/L de 0.00, representando um desvio de 0% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Akers Biosciences (AKER) stock?

Investir em ações de Akers Biosciences (AKER) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Akers Biosciences (AKER) yield today?

A rentabilidade de Akers Biosciences (AKER) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Akers Biosciences (AKER) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

AKER

Akers Biosciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment AKER

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING AKER WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Akers Biosciences

Akers Biosciences Inc.

United States

37 years

2014

4

PROFIT X PRICE AKER

Financial Results AKER

AKER cash flow

Asset, Revenue and Profit Growth - AKER

AKER balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions